Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level

Amparo Santamaría; Antonio Martínez-Rubio; Montserrat Borrell; José Mateo; Rosa Ortín; Jordi Fontcuberta

Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level

Amparo Santamaría, Antonio Martínez-Rubio, Montserrat Borrell, José Mateo, Rosa Ortín, Jordi Fontcuberta

Research output: Contribution to journal › Article › Research › peer-review

Abstract

To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.

Original language	English
Pages (from-to)	880-881
Journal	Haematologica
Volume	89
Issue number	7
Publication status	Published - 1 Jul 2004

Keywords

Arterial
Coronary
TAFI
Thrombosis

Cite this

@article{aedee2d901584196a16432faca8a8ec6,

title = "Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level",

abstract = "To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.",

keywords = "Arterial, Coronary, TAFI, Thrombosis",

author = "Amparo Santamar{\'i}a and Antonio Mart{\'i}nez-Rubio and Montserrat Borrell and Jos{\'e} Mateo and Rosa Ort{\'i}n and Jordi Fontcuberta",

year = "2004",

month = jul,

day = "1",

language = "English",

volume = "89",

pages = "880--881",

number = "7",

}

TY - JOUR

T1 - Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level

AU - Santamaría, Amparo

AU - Martínez-Rubio, Antonio

AU - Borrell, Montserrat

AU - Mateo, José

AU - Ortín, Rosa

AU - Fontcuberta, Jordi

PY - 2004/7/1

Y1 - 2004/7/1

N2 - To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.

AB - To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.

KW - Arterial

KW - Coronary

KW - TAFI

KW - Thrombosis

M3 - Article

SN - 0390-6078

VL - 89

SP - 880

EP - 881

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level

Abstract

Keywords

Fingerprint

Cite this